Keeler & Nadler Financial Planning & Wealth Management Abb Vie Inc. Transaction History

Keeler & Nadler Financial Planning & Wealth Management

$182 Billion
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Oct 03, 2024	SELL	$154.79 - $180.76 $174,138 - $203,355	-1,125 Closed	0 $0
Q1 2024 Oct 03, 2024	BUY	$159.82 - $182.1 $179,797 - $204,862	1,125 New	1,125 $205 Million

Others Institutions Holding ABBV

# of Institutions

3,697

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

Vanguard Group Inc Valley Forge, PA

171M
Shares

$33.3 Billion
0.57% of portfolio
Black Rock Inc. New York, NY

136M
Shares

$26.7 Billion
0.54% of portfolio
State Street Corp Boston, MA

77.8M
Shares

$15.2 Billion
0.59% of portfolio
Jpmorgan Chase & CO New York, NY

53.6M
Shares

$10.5 Billion
0.81% of portfolio
Capital International Investors Los Angeles, CA

38.6M
Shares

$7.54 Billion
1.4% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $345B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keeler & Nadler Financial Planning & Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Keeler & Nadler Financial Planning & Wealth Management with notifications on news.

Account